Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sestamibi parathyroid imaging

M McBiles1, A T Lambert, M G Cote

  • 1Department of Radiology, Fitzsimons Army Medical Center, Aurora, CO 80045-5001, USA.

Seminars in Nuclear Medicine
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coping with PACS downtime in digital radiology.

Journal of digital imaging·2004
Same author

Morphology of calretinin and tyrosine hydroxylase-immunoreactive neurons in the pig retina.

Molecules and cells·2001
Same author

Transverse myelitis in a patient with long-standing ankylosing spondylitis.

Clinical and experimental rheumatology·2001
Same author

Fatal strongyloides hyper-infection in a patient with rheumatoid arthritis.

Clinical and experimental rheumatology·2001
Same author

Ester and hydroxamate analogues of methionyl and isoleucyl adenylates as inhibitors of methionyl-tRNA and isoleucyl-tRNA synthetases.

Bioorganic & medicinal chemistry letters·2001
Same author

Vanilloid and isovanilloid analogues as inhibitors of methionyl-tRNA and isoleucyl-tRNA synthetases.

Bioorganic & medicinal chemistry letters·2001
Same journal

Letter from the Editors.

Seminars in nuclear medicine·2026
Same journal

Expanding Horizons: The Role of Kaleidoscope and Relevant Images in Seminars in Nuclear Medicine.

Seminars in nuclear medicine·2026
Same journal

The diagnostic performance and clinical value of [18F]FDG PET/CT in pleural mesothelioma - A systematic review and meta-analysis.

Seminars in nuclear medicine·2026
Same journal

Feasibility of treating neuroendocrine prostate cancer with anti-SSTR radioligands: A systematic review of imaging and treatment studies.

Seminars in nuclear medicine·2026
Same journal

<sup>18</sup>F-FDG -PET/CT in cardiac sarcoidosis: Diagnosis, therapy monitoring, and future directions.

Seminars in nuclear medicine·2026
Same journal

Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer.

Seminars in nuclear medicine·2026
See all related articles

Technetium-99m (99mTc) sestamibi imaging is the preferred scintigraphic method for parathyroid localization, outperforming other noninvasive techniques. While effective for adenomas, its accuracy for hyperplastic glands and routine preoperative use remains debated.

Area of Science:

  • Nuclear Medicine
  • Radiopharmacology
  • Endocrine Surgery Imaging

Background:

  • Technetium-99m (99mTc) sestamibi has been a key parathyroid imaging agent since 1989.
  • Its utility for localizing parathyroid adenomas is well-established, though less so for hyperplastic glands.
  • Comparative studies show sestamibi protocols are superior to or equal to other noninvasive imaging methods.

Purpose of the Study:

  • To evaluate the diagnostic utility of sestamibi-based parathyroid imaging protocols.
  • To compare sestamibi imaging with other noninvasive imaging strategies and older scintigraphic techniques.
  • To assess the role of sestamibi imaging in primary and reoperative hyperparathyroidism.

Main Methods:

  • Review of imaging protocols utilizing 99mTc sestamibi for parathyroid localization.

Related Experiment Videos

  • Comparison of sestamibi subtraction imaging (with 123I or 99mTc pertechnetate) and dual-phase sestamibi imaging.
  • Analysis of pooled data on sensitivity, specificity, and positive predictive value compared to thallium-201 subtraction imaging.

    • Main Results:

    • Sestamibi subtraction imaging demonstrated higher sensitivity (87%) than thallium-201 subtraction imaging (71%).
    • Dual-phase sestamibi imaging sensitivity varied (43%-91%), with a pooled sensitivity of 73%, generally outperforming thallium-201 techniques.
    • Both sestamibi techniques exhibit high specificity and positive predictive values, typically exceeding 90%.

    Conclusions:

    • 99mTc sestamibi protocols are the scintigraphic procedure of choice for parathyroid imaging due to superior characteristics.
    • Dual-phase sestamibi imaging is robust, suitable for SPECT, and can be combined with subtraction techniques if needed.
    • While excellent for reoperative hyperparathyroidism, its routine use before initial surgery is still debated compared to surgical expertise.